βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
Authors
Keywords
-
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-03
DOI
10.1186/s12885-018-4929-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic immune-inflammation index in germ-cell tumours
- (2018) Michal Chovanec et al. BRITISH JOURNAL OF CANCER
- Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
- (2017) Michal Chovanec et al. Oncotarget
- Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014
- (2016) N. Adra et al. ANNALS OF ONCOLOGY
- Is the Wnt/β catenin signalling pathway activated in Seminoma?: An immunohistochemical study
- (2016) PalaoroLuis Alberto et al. Journal of Cancer Research and Therapeutics
- Immune cell recruitment in teratomas is impaired by increased Wnt secretion
- (2016) Iris Augustin et al. Stem Cell Research
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- β-Catenin Signaling Drives Differentiation and Proinflammatory Function of IRF8-Dependent Dendritic Cells
- (2014) Sara B. Cohen et al. JOURNAL OF IMMUNOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Beta-Catenin Is Vital for the Integrity of Mouse Embryonic Stem Cells
- (2014) Angelo Raggioli et al. PLoS One
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Human Embryonic Stem Cells and Embryonal Carcinoma Cells Have Overlapping and Distinct Metabolic Signatures
- (2012) Raed Abu Dawud et al. PLoS One
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
- (2011) Derk ten Berge et al. NATURE CELL BIOLOGY
- Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas
- (2010) Salvatore Ulisse et al. BMC CANCER
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- The ground state of embryonic stem cell self-renewal
- (2008) Qi-Long Ying et al. NATURE
- Further characterization of the first seminoma cell line TCam-2
- (2007) Jeroen de Jong et al. GENES CHROMOSOMES & CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started